This trial is designed as a prospective, multi-center, observational study of all-comers eligible adult subjects presenting to participating Emergency Departments (EDs) with symptoms suggestive of ACS and/or myocardial ischemia. Subjects presenting with symptoms suggestive of ACS will be screened and approached for consent for study enrollment by trained personnel.~After obtaining written informed consent, subjects will have up to 4 blood samples collected for cTnI testing using the Meritas Troponin I test and Meritas point-of-care (POC) Analyzer. Blood draws and testing will occur at 4 intervals over 24 hours.
This trial is designed as a prospective, multi-center, observational study of all-comers eligible adult subjects presenting to participating emergency departments with symptoms suggestive of acute coronary syndrome (ACS)